Clinical Trial Update: Treosulfan-Based Versus Clofarabine-Based Conditioning Before Donor Hematopoietic Stem Cell Transplant for the Treatment of Myelodysplastic Syndromes or Acute Myeloid Leukemia [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial compares treosulfan-based versus clofarabine-based conditioning regimens before donor allogeneic stem cell transplantation in patien…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• Clolar (Clofarabine)
• Treosulfan (treosulfan)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Acute Myeloid Leukemia, Myelodysplastic Syndrome | Phase 2 | Status: ACTIVE_NOT_RECRUITING